Independent research · 14 pp · PDF, 15 MB
The ESG Advantage
Forging resilience and value at RPG Life Sciences
Overview
An ESG value case on a listed Indian pharma compounding +707% against peers while macro carbon pressure rises: quantifies a ₹5.65 Cr annual carbon-tax exposure, maps strategic materiality, and frames how to decouple financial performance from environmental impact.